Changes in the 2026 program
New schemes and products
- 2708 Human Erythropoietin and Thrombopoietin
- 2709 Phosphatidyl ethanol in blood (PEth)
- 2755 Biochemical indicators of vitamin B12 deficiency (HoloTC, MMA, Homocysteine)
- 2756 Immunosuppressants
- 5043 Gram stain, vaginal fluid
- 5241 Bordetella pertussis/parapertussis, nucleic acid detection
- 5305 Bacterial vaginosis and vaginitis multiplex, nucleic acid detection
- 5688 West Nile virus, antibodies
- 5689 HCV RNA from capillary blood, POCT
- 6800 HPV-related head and neck cancer control
Planned pilot schemes
Pilot schemes are EQA schemes in product development.
All changes are listed in the Product Catalogue on page 5.
2025 program
Download this year's catalogue here.
Sales and Customer Service
Juha Wahlstedt
Sales Director
juha.wahlstedt@aurevia.com
+358 50 327 5338
Jukka Korhonen
Key Account Manager
jukka.korhonen@aurevia.com
+358 50 540 9351
Minna Kankainen
Customer Service Manager
minna.kankainen@aurevia.com
+358 45 131 1682
EQA Product Catalogue
Our external quality assessment service program includes more than 250 quality assessment schemes, covering all specialities of laboratory medicine. Furthermore, the program includes an extensive selection of services designed for medical laboratories and point-of-care testing sites.
Integrated EQA Service
Integrated EQA service is a completely new approach to external quality assessment. New programs integrate pre- and post-analytical EQA schemes into traditional analytical EQA providing support according to the ISO 15189 standard requirements.
.jpg)
New EQA Schemes
We actively follow the development of laboratory medicine as we want to produce clinically relevant EQA schemes to serve clinical laboratories and point-of-care sites. We launch new pilot studies on a regular basis and aim to increase our EQA portfolio with 5-10 new EQA schemes every year.
Digital External Quality Assessment Programs
Our digital EQA product line provides an advanced approach to external quality assessment. Digital EQA programs or virtual EQA programs use digital images, videos, virtual microscopy technology, and questionnaires as EQA samples.
New EQA Pilot Studies 2025
Register for this autumn's new EQA pilot studies! They will be conducted starting in October.
The importance of a robust Design and Development (D&D) process in medical device companies
In the competitive and highly regulated world of medical technology, a robust and well-structured Design and...
Tough times require sharp strategies – and the right expertise
Investments in the development of pharmaceuticals and medtech are more cautious, and Ulrika Hammarström, Head of CRO at...
On-demand ICH GCP E6 (R3) training course
Our online ICH GCP course is designed for students, medical practitioners, nurses, and clinical research professionals...
Does the Health Technology Assessment Regulation (HTAR) include medical devices?
The Health Technology Assessment Regulation (HTAR), officially known as Regulation (EU) 2021/2282, marks an advancement...